Expanded Access for Anti-IL8

Brief Summary

This is an expanded access designed to provide access to Anti-IL8 for eligible participants.

Status

Available

EA Type

Individual Patients

Interventions

Biological: Anti-IL8

Contacts

BMS Study Connect Contact Center www.BMSStudyConnect.com
855-907-3286
Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Investigators

Bristol-Myers Squibb
Study Director
Bristol-Myers Squibb

NCT Number

NCT05210894

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1900 L Street NW, Suite 835
Washington, DC 20036

admin@reaganudall.org

Bristol-Myers Squibb

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA